MBS Pharma AB

ABActive

Org 5591440135Anders Möllares Väg 28, 237 41 BjärredResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2018 · 8 years old0 employees

Overview

MBS Pharma AB is a Swedish AB based in Bjärred, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2018, the company has 0 employees and reported revenue of SEK 748.4k in its latest annual filing.

Revenue 2025

0.7M SEK

−21% vs 2024

EBITDA margin

16.9 %

−49% vs 2024

Net profit 2025

0.1M SEK

-51% vs 2024

Key ratios

See full ratios →

65.9 %

Average

Around the average of companies in the same industry

20212025

3.9×

Average

Around the average of companies in the same industry

20212025

4.2 %

Average

Around the average of companies in the same industry

20212025

EBITDA — year on year

SEK thousands

Key figures

Annual report 2025

Revenue	0.7M SEK	-21%
EBITDA	0.1M SEK	-49%
Net profit	0.1M SEK	-51%
Total assets	1.7M SEK	-3%
Equity	1.1M SEK	+7%
Employees	0	—

Contact

Address

Anders Möllares Väg 28, 237 41 Bjärred

joham.lund@gmail.com

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Financial development

In its most recent annual report (2025), MBS Pharma AB reported revenue of SEK 748.4k, a decrease of 21% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of SEK 70.5k, and the EBITDA margin stood at 16.9%.

At the end of 2025, equity financed 65.9% of the balance sheet, and current assets covered short-term debt 3.9 times.

Financials

Revenue

SEK thousands

EBITDA

SEK thousands

Income statement

SEK thousands

Item	2025	2024	2023	2022	2021
Revenue	748	950	914	711	511
Staff expenses	—	-0	-4	—	—
EBITDA	126	248	575	410	378
Depreciation & amort.	—	—	—	—	-0
EBIT	126	248	575	410	378
Net financials	-1	-1	-2	-357	—
Profit before tax	91	183	425	36	284
Tax	-21	-40	-91	-10	-61
Net profit	71	143	334	26	223

Get a credit rating – not just the numbers

Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.

See the credit rating

Balance sheet

SEK thousands

Item	2025	2024	2023	2022	2021
Total assets	1,676	1,725	1,342	709	603
Equity	1,104	1,034	535	345	319
Long-term debt	—	—	—	—	0
Short-term debt	126	279	459	253	190
Total debt	126	279	459	253	190

Financial ratios

5-year trend

EBITDA margin

16.9 %

20212025

Equity ratio

65.9 %

Average

Around the average of companies in the same industry

20212025

Return on equity

6.4 %

Average

Around the average of companies in the same industry

20212025

Net profit margin

9.4 %

Average

Around the average of companies in the same industry

20212025

Asset turnover

0.45×

Average

Around the average of companies in the same industry

20212025

Debt / equity

0.52×

Strong

Among the 30% highest rated companies in the industry

20212025

Sector performance

25 of 28 ratios graded

28 financial ratios from the latest filing, each graded against companies in the same industry.

Profitability

Gross marginAverage

Around the average of companies in the same industry

The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.

Operating marginAverage

Around the average of companies in the same industry

EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.

Net profit marginAverage

Around the average of companies in the same industry

The profit for the year as a share of revenue — the company's ability to turn revenue into profit.

Return on equity (ROE)Average

Around the average of companies in the same industry

Net profit as a percentage of equity — the return the owners earned on their invested capital this year.

Return on assets (ROA)Average

Around the average of companies in the same industry

Net profit as a percentage of total assets — the return generated on the capital employed.

Return on net assets (RONA)Average

Around the average of companies in the same industry

Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.

Basic earning power (BEP)Average

Around the average of companies in the same industry

EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.

Capacity ratioAverage

Around the average of companies in the same industry

Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.

Liquidity

Current ratioAverage

Around the average of companies in the same industry

Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.

Cash ratioAverage

Around the average of companies in the same industry

Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.

Current assets to equityVery strong

Among the 20% highest rated companies in the industry

Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.

Cash conversion ratioVery strong

Among the 20% highest rated companies in the industry

Cash flow relative to profit — the ability to convert reported profits into accessible cash.

Quick ratioNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.

Fixed assets to long-term capitalNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.

Debt & solvency

Solidity ratioAverage

Around the average of companies in the same industry

Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.

Debt ratioVery strong

Among the 20% highest rated companies in the industry

Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.

Debt to equityStrong

Among the 30% highest rated companies in the industry

Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.

Liabilities to equityAverage

Around the average of companies in the same industry

Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.

Income to debtStrong

Among the 40% highest rated companies in the industry

Profit relative to debt — the ability to create earnings while operating with debt.

EBITDA to debtStrong

Among the 30% highest rated companies in the industry

EBITDA relative to debt — how much operating earnings are available to service the debt.

Interest coverageStrong

Among the 40% highest rated companies in the industry

The ability to pay the interest on the company's debt out of its earnings.

Interest rate on debtAverage

Around the average of companies in the same industry

Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.

Interest marginAverage

Around the average of companies in the same industry

The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.

Efficiency & development

Asset turnoverAverage

Around the average of companies in the same industry

Revenue relative to total assets — the ability to generate revenue from the asset base.

Equity to contributed capitalStrong

Among the 40% highest rated companies in the industry

Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.

One-year change in equityStrong

Among the 40% highest rated companies in the industry

The size of this year's increase or decrease in the company's equity.

One-year change in debtVery strong

Among the 20% highest rated companies in the industry

The size of this year's increase or decrease in the company's debt.

Inventory turnoverNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.

Annual reports & filings

Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31

People & ownership

Management

Actively employed in the business

No data on file.

Board of directors

Non-executive oversight

Name	Role	Member since
Current (2)
JL Johan Lars Fredrik Lund Board of Directors	Board of Directors	2022
LR Lena Ragnhild Ingeborg Ahlgren Deputy Board Member	Deputy Board Member	2022

Shareholders

Active legal owners

No shareholder data available.

One in three Danish companies experiences fraud

Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.

See the fraud module

Related companies

Company hierarchy

No registered parent or subsidiaries

Board network connections

Board members of MBS Pharma AB also hold positions in 5 other companies.

Person	Role here	Other companies
Johan Lars Fredrik Lund	Board of Directors	5 companies

Frequently asked questions

What is the Org number of MBS Pharma AB?

MBS Pharma AB is registered with Bolagsverket / SCB under Org 5591440135.

What is the revenue of MBS Pharma AB?

MBS Pharma AB reported revenue of SEK 748.4k in 2025.

Where is MBS Pharma AB headquartered?

MBS Pharma AB's registered address is Anders Möllares Väg 28.